Skip to main content
. 2016 May 24;7(26):40221–40232. doi: 10.18632/oncotarget.9574

Figure 3.

Figure 3

A. Risk of recurrences in case of positivity for L1CAM expression in the endometrial cancer cohort. Odds ratio (OR) for the probability of experiencing a recurrence (both local and distant) for positive values of L1CAM. B. Risk of pelvic lymph node metastasis at diagnosis. Odds ratio (OR) for expression of L1CAM, methylation of L1CAM, risk assessment, myometrial infiltration and high-low grade cancers. The bars indicate the value of the odds ratio and the confidence intervals at 95%.